1810-74-8

Basic information

• Product Name: 7-METHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE
• Synonyms: 7-METHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE;AKOS BBS-00005636;ASISCHEM Y53008;2,2,4-Trimethyl-7-methoxy-1,2-dihydroquinoline;1,2-Dihydro-7-Methoxy-2,2,4-triMethylquinoline;Quinoline, 1,2-dihydro-7-Methoxy-2,2,4-triMethyl-;7-methoxy-2,2,4-trimethyl-1H-quinoline
• CAS NO: 1810-74-8
• Molecular Formula: C₁₃H₁₇NO
• Molecular Weight: 203.28
• Mol File: 1810-74-8.mol
• Article Data: 29

Chemical Properties

• Melting Point: 67-69℃
• Boiling Point: 306℃
• Flash Point: 125℃
• Appearance: /Solid
• Density: 0.986
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: DMSO (Slightly), Methanol (Slightly)
• PKA: 3.83±0.70(Predicted)
• CAS DataBase Reference: 7-METHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-METHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE(1810-74-8)
• EPA Substance Registry System: 7-METHOXY-2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE(1810-74-8)

Safety Data

• Hazardous Substances Data: 1810-74-8(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 1810-74-8 differently. You can refer to the following data:
1. 7-Methoxy-2,2,4-trimethyl-1,2-dihydroquinoline is a 1,2-dihydroquinoline derivative with antiinflammatory activity. IT is used in the preparation of fluorescent dyes biological microscopy and nanoscop y.
2. 7-Methoxy-2,2,4-trimethyl-1,2-dihydroquinoline is a 1,2-dihydroquinoline derivative with antiinflammatory activity. IT is used in the preparation of fluorescent dyes biological microscopy and nanoscopy.

Upstream product

• 536-90-3 m-Anisidine 
• 67-64-1 acetone 
• 4286-55-9 1-bromo-6-hexanol 
• 7087-68-5 N-ethyl-N,N-diisopropylamine 
• 74-99-7 prop-1-yne 
• 141-79-7 4-methyl-pent-3-en-2-one 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 1211325-03-9 10-methoxy-5,5,7-trimethyl-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline 
• 41381-74-2 7-methoxy-1,2,2,4-tetramethyl-1,2,3,4-tetrahydroquinoline 
• 41381-69-5 7-methoxy-1,2,2,4-tetramethyl-1,2,3,4-tetrahydroquinoline-6-carbaldehyde 
• 1417732-42-3 (E)-1-(2-ethoxy-2-oxoethyl)-4-(2-(7-methoxy-1,2,2,4-tetramethyl-1,2,3,4-tetrahydroquinolin-6-yl)vinyl)pyridin-1-ium bromide 
• 1417732-50-3 C₁₈H₂₂N₂O₃ 
• 63095-11-4 (R/S)-1,2,3,4-tetrahydro-7-hydroxy-2,2,4-trimethylquinoline 
• 1448822-28-3 C₁₈H₂₇NO₃ 

Relevant articles and documents

Efficient green coumarin dopants for organic light-emitting devices

We have synthesized a new green fluorescent dopant C-545P having incorporated five strategically placed "methyl" steric spacers on the julolidyl ring system. C-545P has good thermal properties and photostability, and when fabricated as a dopant in an Alq3-hosted OLED device, it shows notable improvement in luminance efficiency and is more resistant to concentration quenching than C-545T, particularly in the doping concentration range between 1 and 2% v/v, while achieving comparable device stability.

7-methoxy-2,2,4-trimethyl-1,2-dihydroquinoline

The title compound, C13H17NO, was prepared using a new class of activator, alkyl bromides. The heterocyclic ring adopts a non-planar conformation, which contrasts with the conformations found for related compounds.

NEAR-INFRARED NERVE-SPARING FLUOROPHORES

Provided are far red to near-infrared nerve-sparing fluorescent compounds, compositions comprising them, and methods of their use in medical procedures.

MADRASIN-DERIVATIVE COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER

The present invention relates to the fields of medicine and in particular cancer treatment. The invention more specifically relates to new compounds which are typically for use as a medicament. In particular, the invention relates to the use of these new compounds for increasing the presentation, typically the production and presentation, of Pioneer Translation Products (PTPs)-derived antigens by cells, in particular cancer cells, or changing the immunopeptidome, in a subject, and inducing or stimulating an immune response in the subject. The present disclosure also relates to uses of such compounds, in particular to prepare a pharmaceutical composition and/or to allow or improve the efficiency of a therapy in a subject in need thereof. The invention also discloses methods for treating a disease, in particular cancer, for preventing or treating cancer metastasis and/or cancer recurrence, in a subject. The present invention in addition provides kits suitable for preparing a composition according to the present invention and/or for implementing the herein described methods.

Fluorescence Compounds and Preparation Method Therof

An object of the present invention is to provide a fluorescent compound which is excellent in fluorescence intensity, relative quantum efficiency, and a labeling ratio, thereby being able to be used as a contrast agent composition, and a labeling method using the same. The fluorescent compound according to the present invention is superior in terms of fluorescence intensity, relative quantum efficiency, and the labeling ratio, thereby being able to be effectively used for labeling and dyeing a target material. In addition, the fluorescent compound has excellent optical stability, thereby exhibiting stable fluorescence even for a long time of dyeing, and since the fluorescent compound has excellent fluorescence intensity without accumulation during administration to the body, it is possible to easily perform dyeing and in-vivo imaging even when a small amount of a dye is used compared to conventional dyes, thereby being economically available.(AA) Compound 1-3 (0.013 andmu;M)COPYRIGHT KIPO 2019